U.S. market Closed. Opens in 1 day 3 hours 52 minutes

ZBH | Zimmer Biomet Holdings, Inc. Stock Fundamentals

(Stock Exchange: NYSE)
Analyzing fundamentals for ZBH we got that it has average fundamentals where Valuation is considered to be undervalued, Profitability is very poor, Growth is on medium level and Health is passable.

Valuation (79%)

Company Industry
P/E Ratio (TTM) 20.00 35.44
PEG Ratio (TTM) 2.14 -2.74
P/S Ratio (TTM) 2.81 6.39
P/B Ratio (TTM) 1.75 5.95
P/FCF Ratio (TTM) 18.42 45.33
Price to 5YR AVG Earnings Ratio 41.88 62.55
Price to 5YR AVG FCF Ratio 18.02 34.45

Profitability (35%)

Company Industry
ROA (TTM) 4.99% 5.33%
ROE (TTM) 8.64% 26.24%
Net Profit Margin (TTM) 14.27% 0.94%
ROIC 5YR AVG 5.37% 4.32%

Growth (60%)

4QTR AVG 3YR AVG 5YR AVG
EPS 36.05% 225.75% 180.50%
Revenue 1.19% -4.73% -1.20%
Net Income 35.56% 226.19% 195.74%
Cash Flow 20.54% -2.94% -0.01%

Health (51%)

Company Industry
Current Ratio (TTM) 1.36 2.59
Quick Ratio (TTM) 0.70 1.96
D/E Ratio (TTM) 0.52 -0.04
Interest Coverage (TTM) 6.67 13.08
Piotroski F-Score 8 6
Altman Z-Score 2.68 7.11
LTL to 5YR AVG FCF 4.26 3.62
Shares Outstanding Growth 5YR AVG 0.51% 2.25%
An error has occurred. This application may no longer respond until reloaded. Reload 🗙